全文获取类型
收费全文 | 106篇 |
免费 | 2篇 |
专业分类
系统科学 | 5篇 |
理论与方法论 | 3篇 |
现状及发展 | 43篇 |
研究方法 | 10篇 |
综合类 | 41篇 |
自然研究 | 6篇 |
出版年
2021年 | 1篇 |
2020年 | 3篇 |
2018年 | 2篇 |
2017年 | 1篇 |
2016年 | 5篇 |
2015年 | 4篇 |
2014年 | 4篇 |
2013年 | 4篇 |
2012年 | 8篇 |
2011年 | 9篇 |
2010年 | 3篇 |
2009年 | 1篇 |
2008年 | 4篇 |
2007年 | 10篇 |
2006年 | 4篇 |
2005年 | 2篇 |
2004年 | 4篇 |
2003年 | 5篇 |
2002年 | 2篇 |
2000年 | 2篇 |
1999年 | 1篇 |
1992年 | 2篇 |
1991年 | 1篇 |
1987年 | 1篇 |
1985年 | 1篇 |
1984年 | 2篇 |
1982年 | 3篇 |
1981年 | 4篇 |
1980年 | 1篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1975年 | 3篇 |
1974年 | 2篇 |
1970年 | 3篇 |
1969年 | 1篇 |
1968年 | 1篇 |
1966年 | 2篇 |
排序方式: 共有108条查询结果,搜索用时 15 毫秒
101.
102.
103.
104.
105.
106.
Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells 总被引:1,自引:0,他引:1
Lister R Pelizzola M Kida YS Hawkins RD Nery JR Hon G Antosiewicz-Bourget J O'Malley R Castanon R Klugman S Downes M Yu R Stewart R Ren B Thomson JA Evans RM Ecker JR 《Nature》2011,471(7336):68-73
Induced pluripotent stem cells (iPSCs) offer immense potential for regenerative medicine and studies of disease and development. Somatic cell reprogramming involves epigenomic reconfiguration, conferring iPSCs with characteristics similar to embryonic stem (ES) cells. However, it remains unknown how complete the reestablishment of ES-cell-like DNA methylation patterns is throughout the genome. Here we report the first whole-genome profiles of DNA methylation at single-base resolution in five human iPSC lines, along with methylomes of ES cells, somatic cells, and differentiated iPSCs and ES cells. iPSCs show significant reprogramming variability, including somatic memory and aberrant reprogramming of DNA methylation. iPSCs share megabase-scale differentially methylated regions proximal to centromeres and telomeres that display incomplete reprogramming of non-CG methylation, and differences in CG methylation and histone modifications. Lastly, differentiation of iPSCs into trophoblast cells revealed that errors in reprogramming CG methylation are transmitted at a high frequency, providing an iPSC reprogramming signature that is maintained after differentiation. 相似文献
107.
The first hominin of Europe 总被引:3,自引:0,他引:3
Carbonell E Bermúdez de Castro JM Parés JM Pérez-González A Cuenca-Bescós G Ollé A Mosquera M Huguet R van der Made J Rosas A Sala R Vallverdú J García N Granger DE Martinón-Torres M Rodríguez XP Stock GM Vergès JM Allué E Burjachs F Cáceres I Canals A Benito A Díez C Lozano M Mateos A Navazo M Rodríguez J Rosell J Arsuaga JL 《Nature》2008,452(7186):465-469
The earliest hominin occupation of Europe is one of the most debated topics in palaeoanthropology. However, the purportedly oldest of the Early Pleistocene sites in Eurasia lack precise age control and contain stone tools rather than human fossil remains. Here we report the discovery of a human mandible associated with an assemblage of Mode 1 lithic tools and faunal remains bearing traces of hominin processing, in stratigraphic level TE9 at the site of the Sima del Elefante, Atapuerca, Spain. Level TE9 has been dated to the Early Pleistocene (approximately 1.2-1.1 Myr), based on a combination of palaeomagnetism, cosmogenic nuclides and biostratigraphy. The Sima del Elefante site thus emerges as the oldest, most accurately dated record of human occupation in Europe, to our knowledge. The study of the human mandible suggests that the first settlement of Western Europe could be related to an early demographic expansion out of Africa. The new evidence, with previous findings in other Atapuerca sites (level TD6 from Gran Dolina), also suggests that a speciation event occurred in this extreme area of the Eurasian continent during the Early Pleistocene, initiating the hominin lineage represented by the TE9 and TD6 hominins. 相似文献
108.
PML targeting eradicates quiescent leukaemia-initiating cells 总被引:1,自引:0,他引:1
Ito K Bernardi R Morotti A Matsuoka S Saglio G Ikeda Y Rosenblatt J Avigan DE Teruya-Feldstein J Pandolfi PP 《Nature》2008,453(7198):1072-1078
The existence of a small population of 'cancer-initiating cells' responsible for tumour maintenance has been firmly demonstrated in leukaemia. This concept is currently being tested in solid tumours. Leukaemia-initiating cells, particularly those that are in a quiescent state, are thought to be resistant to chemotherapy and targeted therapies, resulting in disease relapse. Chronic myeloid leukaemia is a paradigmatic haematopoietic stem cell disease in which the leukaemia-initiating-cell pool is not eradicated by current therapy, leading to disease relapse on drug discontinuation. Here we define the critical role of the promyelocytic leukaemia protein (PML) tumour suppressor in haematopoietic stem cell maintenance, and present a new therapeutic approach for targeting quiescent leukaemia-initiating cells and possibly cancer-initiating cells by pharmacological inhibition of PML. 相似文献